Comments
Loading...
Durect (NASDAQ:DRRX) Stock Quotes, Forecast and News Summary
Durect Stock (NASDAQ: DRRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Durect (DRRX) stock?
You can purchase shares of Durect (NASDAQ:DRRX) through any online brokerage.
Who are Durect (DRRX) competitors?
Other companies in Durect’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Lipocine (NASDAQ:LPCN).
What is the forecast, or price target, for Durect (DRRX) stock?
Durect has a consensus price target of $23.00.
What is the current price for Durect (DRRX)?
The stock price for Durect (NASDAQ: DRRX) is $0.979999 last updated November 20, 2024 at 10:03 AM EST.
Does Durect (DRRX) pay a dividend?
There are no upcoming dividends for Durect.
When is Durect (NASDAQ:DRRX) reporting earnings?
Durect’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Durect (DRRX) going to split?
There is no upcoming split for Durect.
What sector and industry does Durect (DRRX) operate in?
Durect is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.